The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characterization of rectal cancer in patients with Lynch syndrome.
Zsofia Kinga Stadler
No relevant relationships to disclose
Jinru Shia
No relevant relationships to disclose
Karyn A. Goodman
No relevant relationships to disclose
Andrea Cercek
Research Funding - Astellas Pharma
Neil Howard Segal
No relevant relationships to disclose
Diane Lauren Reidy
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - ImClone Systems; Merck; Novartis
Rona D. Yaeger
No relevant relationships to disclose
Garrett Michael Nash
No relevant relationships to disclose
Larissa K. F. Temple
No relevant relationships to disclose
Nancy E. Kemeny
Honoraria - Amgen
Research Funding - Amgen
Martin R. Weiser
No relevant relationships to disclose
David Paul Kelsen
No relevant relationships to disclose
Arnold Markowitz
No relevant relationships to disclose
Mark E. Robson
No relevant relationships to disclose
Kenneth Offit
No relevant relationships to disclose
Philip Paty
No relevant relationships to disclose
Jose G. Guillem
No relevant relationships to disclose
Leonard Saltz
No relevant relationships to disclose